Submissions
Kevin Outterson of West Virginia University College of Law
2 February 2006
-
Patent Buy-Outs For Global Disease Innovations For Low- and Middle-Income Countries
pdf, 492kb -
Fair followers: Expanding access to generic pharmaceuticals for low-income populations
pdf, 352kb
Dr Andrew Gilman, Professor Ted Schrecker, Dr Robert Clarke, Robert Hawkes, Institute of Population Health, Canada
21 November 2005
USP International Health Expert Committee
21 November 2005
Donald W. Light, Professor of Comparative Health Care Systems, University of Medicine and Dentistry of New Jersey
3 November 2005
Itaru Nitta, School of International Service, American University, Washington, D.C. and Wakabayashi Intellectual Property Law, Tokyo
29 September 2005
-
Patents and Essential Medicines: an Application of the Green Intellectual Property Project
pdf, 204kb
Dr Tim Hubbard, Head of Human Genome Analysis, Sanger Institute
22 August 2005
Professor Luigi Orsenigo, University of Brescia
26 July 2005
Richard Nelson, Henry R. Luce Professor of International Political Economy, Columbia University
26 July 2005
Rochelle Dreyfuss, Pauline Newman Professor of Law, New York University School of Law
26 July 2005
F. M. Scherer,Aetna Professor Emeritus, John F. Kennedy School of Government, Harvard University; and lecturer with the rank of professor, Woodrow Wilson School of Public and International Affairs, Princeton University
26 July 2005
Frederick Abbott, Professor of International Law, Florida State University
26 July 2005
-
The WTO Medicines decision: World Pharmaceutical Trade and the Protection of Public Health
pdf, 357kb
Mickey Kantor, former US Trade Representative
25 July 2005
Bryan Schwartz, Faculty of Law, University of Manitoba
9 June 2005
International Chamber of Commerce (ICC)
7 June 2005
Dr Fabio Pammolli, Dr Maria Alessandra Rossi
28 May 2005
Biomedical Industry Advisory Group (BIAG)
26 May 2005
World Intellectual Property Secretariat
20 May 2005
Michael Kremer, Adrian Towse, Heidi Williams
19 May 2005
Roy Widdus
17 May 2005
-
Key Stakeholders and Funding of HIV and Malaria Vaccines: Considerations in selecting appropriate instruments for accelerating the public health impact of vaccination in poorer countries
pdf, 408kb -
Executive Summary
pdf, 175kb
André Luis de Almeida dos Reis, Carlos Maria Correa, Egléubia Andrade de Oliveira, Gabriela Costa Chaves, Germán Velasquez
10 May 2005
Owen Barder, Michael Kremer, Ruth Levine
10 May 2005
Wendy Taylor of BIO Ventures for Global Health
10 May 2005
Andrew Farlow, Donald, W. Light, Richard, T. Mahoney,
Roy Widdus
2 May 2005
Jean O. Lanjouw of the Center for Global Development
24 April 2005
Andrew Farlow from Oxford University
23 March 2005
Julian Morris, Philip Stevens & Alec van Gelder from the International Policy Network
18 March 2005
Albert Wertheimer from the International Policy Network
17 March 2005
Robert Sauer of the International Policy Network
9 March 2005
Bradly J Condon and Tapen Sinha of Instituto Tecnologico Autonomo de Mexico, Mexico
3 March 2005
International Policy Network
1 March 2005
CPTech
24 February 2005
Aidan Hollis of the University of Calgary
5 April 2005
Mary Moran of LSE Pharmaceutical R&D Policy Group
7 February 2005
* The author welcomes comments on this paper. Please send any comments you wish to make to M.Moran@lse.ac.uk.